Skip to main content

Advertisement

SpringerLink
Log in

Quality, Value, and Efficacy of Complementary and Alternative Medicine in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome

  • Outcomes in Functional Urology (A Cameron, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a difficult condition to treat, and few treatments have been demonstrated to be effective. Patients are therefore often willing to try treatments that traditional medicine does not offer, such as complementary and alternative medicine (CAM). The purpose of this paper is to review the current CAM treatments for IC/BPS.

Recent Findings

Several modalities have been explored in the treatment of IC/BPS. Dietary modification with the elimination of arylalkylamine-containing foods has been shown to reduce symptom flares. Different nutraceuticals have also been studied. Promising results were shown for calcium glycerophosphate taken before the ingestion of foods responsible for symptom flares. The glycosaminoglycan layer appears to be damaged in this condition, and therefore intravesical and oral therapies targeting this layer have the potential of improving symptoms. Mind–body interventions including yoga, mindfulness-based stress reduction, and hypnosis can improve symptoms, relaxation, and help patients in feeling more empowered. Manipulative approaches such as myofascial physical therapy, transvaginal biofeedback, and intravaginal Thiele massage can improve pelvic floor hypertonicity. Pulsed electromagnetic field therapy and acupuncture with or without moxibustion are associated with a reduction in pain.

Summary

Different areas of complementary and alternative medicine have been studied for the treatment of IC/BPS, including biologically based therapies, mind-body interventions, manipulative and body-based approaches, and whole medical systems. These therapies have shown promising results. However, most of them have a small number of participants and do not provide high-quality evidence regarding their effectiveness. Randomized, placebo-controlled studies should be conducted to establish the efficacy of CAMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208:34–42. (New amendments have been made to the American Urological Association Guidelines on Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome. This guideline provides information with IC/BPS epidemiology, diagnosis, and treatment. Behavioral and non-pharmacological therapies are part of the treatment algorithm. Non-pharmacological treatments that are recommended include self-care practices, stress management, and physical therapy techniques.)

    Article  PubMed  Google Scholar 

  2. Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014;175:30–7.

    Article  CAS  PubMed  Google Scholar 

  3. •• Soriano AJ, Schnur JB, Harvie HS, Newman DK, Montgomery GH, Arya LA. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol Urodyn. 2021;40:1945–54. (Hypnosis for IC/BPS is not extensively present in the literature. This is one of the first articles with a robust methodology that evaluates its effects. This study demonstrates that a randomized, controlled, trial for hypnosis in women with IC/BPS is feasible and acceptable. This study also shows potential benefits in terms of symptom reduction and improved quality of life.)

    Article  PubMed  Google Scholar 

  4. O’Hare PG, Hoffmann AR, Allen P, Gordon B, Salin L, Whitmore K. Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecol J. 2012;24:977–82.

    Article  PubMed  Google Scholar 

  5. Pearson NJ, Chesney MA. The National Center for Complementary and Alternative Medicine. Acad Med. 2007;82:967.

    Article  PubMed  Google Scholar 

  6. Whitmore KE. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol. 2002;4Suppl(Suppl 1):S28–35.

    Google Scholar 

  7. Gillespie L. Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol. 1993;72:293–7.

    Article  CAS  PubMed  Google Scholar 

  8. Kaufman LD, Philen RM. Tryptophan. Drug Saf. 1993;8:89–98.

    Article  CAS  PubMed  Google Scholar 

  9. Oh-oka H. Clinical efficacy of 1-year intensive systematic dietary manipulation as complementary and alternative medicine therapies on female patients with interstitial cystitis/bladder pain syndrome. Urol. 2017;106:50–4.

    Article  PubMed  Google Scholar 

  10. Pang R, Ali A. The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome. Transl Androl Urol. 2015;4(6):653–61.

    PubMed  PubMed Central  Google Scholar 

  11. Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109:1584–91.

    Article  PubMed  Google Scholar 

  12. Bologna RA, Gomelsky A, Lukban JC, Tu LM, Holzberg AS, Whitmore KE. The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology. 2001;57:119–20.

    Article  CAS  PubMed  Google Scholar 

  13. • Okuyama E, Kawatani M, Hashimoto J, Tanimoto K, Hashimoto M, Matsumoto-Miyai K. The nitric oxide-cyclic guanosine monophosphate pathway inhibits the bladder ATP release in response to a physiological or pathological stimulus. Physiol Rep. 2021. https://doi.org/10.14814/phy2.14938. (The mechanism by which NO and NOS were involved in IC/BPS is not completely understood. This recent study further explores its role and the nitric oxide–cyclic guanosine monophosphate pathway under physiological and pathological circumstances.)

    Article  PubMed  PubMed Central  Google Scholar 

  14. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol. 2002;129:4–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.

    Article  CAS  PubMed  Google Scholar 

  16. Cartledge JJ, Davies A-M, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of l-arginine in the treatment of interstitial cystitis. BJU Int. 2000;85:421–6.

    Article  CAS  PubMed  Google Scholar 

  17. Sahiner IF, Soylu H, Ates E, Acar N, Ustunel I, Danısman A. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model. Int Braz J Urol. 2018;44:1014–22.

    Article  PubMed  PubMed Central  Google Scholar 

  18. • Abdal Dayem A, Kim K, Lee SB, Kim A, Cho S-G. Application of adult and pluripotent stem cells in interstitial cystitis/bladder pain syndrome therapy: methods and perspectives. J Clin Med. 2020;9:766. (This article provides a review of the most recent understandings on the pathophysiology and etiology of IC/BPS. It also discusses a novel therapeutic approach: the potential of stem cells in bladder regeneration and its possible applications in IC/BPS treatment.)

    Article  PubMed Central  Google Scholar 

  19. Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996;156:45–8.

    Article  CAS  PubMed  Google Scholar 

  20. Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol. 2002;1:1454–8.

    Google Scholar 

  21. Theoharides TC, Kempuraj D, Vakali S, Sant GR. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek—an oral multi-agent natural supplement. Can J Urol. 2008;6:411–4.

    Google Scholar 

  22. Meng E, Hsu Y-C, Chuang Y-C. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). LUTS: Lower Urin Tract Symptoms. 2018;10:3–11.

    Article  CAS  Google Scholar 

  23. Grundy L, Brierley SM. Cross-organ sensitization between the colon and bladder: to pee or not to pee? Am J Physiol-Gastrointest Liver Physiol. 2018. https://doi.org/10.1152/ajpgi.00272.2017.

    Article  PubMed  Google Scholar 

  24. Tyagi P, Kashyap M, Majima T, Kawamorita N, Yoshizawa T, Yoshimura N. Intravesical liposome therapy for interstitial cystitis. Int J Urol. 2017;24:262–71.

    Article  CAS  PubMed  Google Scholar 

  25. Chuang Y-C, Lee W-C, Lee W-C, Chiang P-H. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol. 2009;182:1393–400.

    Article  CAS  PubMed  Google Scholar 

  26. Peters KM, Kasenau DL, Anthony M, Kaufman J, Killinger KA. Novel therapy with intravesical liposomes for ulcerative interstitial cystitis/painful bladder syndrome. LUTS: Lower Urin Tract Symptoms. 2011;4:51–3.

    Article  Google Scholar 

  27. Kanter G, Komesu Y, Qaedan F, Rogers R. 5: Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2016. https://doi.org/10.1016/j.ajog.2016.01.014.

    Article  PubMed  Google Scholar 

  28. Huang AJ, Rowen TS, Abercrombie P, Subak LL, Schembri M, Plaut T, Chao MT. Development and feasibility of a group-based therapeutic yoga program for women with chronic pelvic pain. Pain Med. 2017;18:1864–72.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ripoll E, Mahowald D. Hatha yoga therapy management of urologic disorders. World J Urol. 2002;20:306–9.

    Article  PubMed  Google Scholar 

  30. Soriano AJ, Schnur JB, Harvie HS, Newman DK, Montgomery GH, Arya LA. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol Urodyn. 2021;40:1945–54.

    Article  PubMed  Google Scholar 

  31. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545–53.

    Article  PubMed  Google Scholar 

  32. •• El-Hefnawy AS, Soliman HM, Abd-Elbary SO, Shereif WI. Long-standing nonulcerative bladder pain syndrome: impact of Thiele massage on bladder and sexual domains. LUTS: Lower Urin Tract Symptoms. 2019;12:123–7. (This is one of the first studies specifically evaluating the impacts of Thiele massage on sexual function in IC/BPS, in addition to pain symptoms. The authors concluded that Thiele massage can have some positive impacts on pain symptoms, but that this technique should not be used as monotherapy. Importantly, Thiele massage appears to be associated with a negative impact on vaginal lubrication and increased vaginal dryness.)

    Article  Google Scholar 

  33. FitzGerald MP, Payne CK, Lukacz ES, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187:2113–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Grundy L, Brierley SM. Cross-organ sensitization between the colon and bladder: to pee or not to pee? Am J Physiol-Gastrointest Liver Physiol. 2018. https://doi.org/10.1152/ajpgi.00272.2017.

    Article  PubMed  Google Scholar 

  35. Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, Whitmore KE. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urol. 2004;64:862–5.

    Article  PubMed  Google Scholar 

  36. Abe-Takahashi Y, Kitta T, Ouchi M, Chiba H, Higuchi M, Togo M, Shinohara N. Examination of pelvic floor muscle elasticity in patients with interstitial cystitis/bladder pain syndrome using real-time tissue elastography. Int Urogynecol J. 2021;33:619–26.

    Article  PubMed  Google Scholar 

  37. • Ross CL, Zhou Y, McCall CE, Soker S, Criswell TL. The use of pulsed electromagnetic field to modulate inflammation and improve tissue regeneration: a review. Bioelectricity. 2019;1:247–59. (This is a review of the published data on the use of PEMF to improve tissue regeneration, as well as its effects on immunomodulatory cells and modulation of inflammatory signaling pathways. The studies included in this article have focused on the effects of PEMF on human and animal tissues and demonstrate its modulatory activity in different stages of the inflammatory response through regulation of pro and anti-inflammatory cytokine secretion.)

    Article  PubMed  PubMed Central  Google Scholar 

  38. Sutbeyaz ST, Sezer N, Koseoglu F, Kibar S. Low-frequency pulsed electromagnetic field therapy in fibromyalgia. Clin J Pain. 2009;25:722–8.

    Article  PubMed  Google Scholar 

  39. •• Wolff DT, Ross C, Lee P, Badlani G, Matthews CA, Evans RJ, Walker SJ. Pulsed electromagnetic field therapy for pain management in interstitial cystitis/bladder pain syndrome: a proof-of-concept case series. Urol. 2022. https://doi.org/10.1016/j.urology.2022.05.021. (This is a single-center, prospective clinical case series that explored the efficacy of PEMF therapy for symptom improvement in females with IC/BPS. Most of the studies prior to this article reported anecdotal experiences with PEMF in females with IC/BPS or its effects in vitro. To our knowledge, this is one of the first studies with a robust methodology that evaluates a larger number of cases. PEMF showed promising results in both symptom quality of life improvement. The authors encouraged further studies to be conducted in this direction.)

    Article  PubMed  Google Scholar 

  40. Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.

    Article  CAS  PubMed  Google Scholar 

  41. Honjo H, Ukimura O, Hirahara N, Ushijima S, Kawauchi A, Kitakoji H, Nakao M, Miki T. 1528: Acupuncture normarized bladder sensory dysfunction of C-fiber in patients with overactive bladder and interstitial cystitis. J Urol. 2007;177:504–5.

    Article  Google Scholar 

  42. Katayama Y, Nakahara K, Shitamura T, Mukai S, Wakeda H, Yamashita Y, Inoue K, Nose K, Kamoto T. Effectiveness of acupuncture and moxibustion therapy for the treatment of refractory interstitial cystitis. Hinokika Kiyo. 2013;5:265–9.

    Google Scholar 

  43. Verghese TS, Riordain RN, Champaneria R, Latthe PM. Complementary therapies for bladder pain syndrome: a systematic review. Int Urogynecol J. 2015;27:1127–36.

    Article  PubMed  PubMed Central  Google Scholar 

  44. •• Komatsu E, Volpe K, Pahwa A. The effect of a diagnosis of interstitial cystitis/bladder pain syndrome: a qualitative approach [36d]. Obstet Gynecol. 2019. https://doi.org/10.1097/01.aog.0000558992.05634.39. (The authors of this study investigated if obtaining a clear diagnosis of IC/BPS could have an impact on patients’ symptom course and coping. Most patients noted an emotional benefit and improvements in treatment when they obtained a diagnosis. This study highlights the importance of validating patients’ experience and that providing them with a diagnosis can make them feel more engaged in their treatment, which appears to be therapeutic in and of itself.)

    Article  Google Scholar 

  45. •• Hassani D, Flick L, Sangha H, Brown LA, Andy U, Arya L. How do women with interstitial cystitis/bladder pain syndrome make treatment choices? Int Urogynecol J. 2021;33:583–93. (The authors of this study explored the factors that could impact patient decision-making when choosing a treatment strategy for IC/BPS. There was a considerable interest amongst patients in self-management of symptoms, which empowered them to cope with IC/BPS despite more difficult periods. Patients wanted to take an active role in their treatment, where many of them would seek out educational resources where they could learn self-care practices.)

    Article  PubMed  PubMed Central  Google Scholar 

  46. Forrest JB, Moldwin R. Diagnostic options for early identification and management of interstitial cystitis/painful bladder syndrome. Int J Clin Pract. 2008;62:1926–34.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, University of Montreal, Montreal, Canada

    Béatrice Bouchard

  2. Division of Urology, Department of Surgery, Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, 3755 Chemin de La Côte-Sainte-Catherine, Montreal, QC, H3T 1E2, Canada

    Lysanne Campeau

Authors
  1. Béatrice Bouchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lysanne Campeau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lysanne Campeau.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Outcomes in Functional Urology.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bouchard, B., Campeau, L. Quality, Value, and Efficacy of Complementary and Alternative Medicine in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Curr Bladder Dysfunct Rep 18, 51–58 (2023). https://doi.org/10.1007/s11884-022-00683-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-022-00683-2

Keywords

Search

Navigation